Disease characteristics in adult-onset dermatomyositis are associated with neighborhood-level area deprivation index [0.03%]
成人皮肌炎的疾病特征与邻里层面的地区剥夺指数有关
Saloni Patel,Ruchita Kothari,Maria Kaltchenko et al.
Saloni Patel et al.
Aaron D Smith,Gabrielle Schwartzman,Jane M Grant-Kels
Aaron D Smith
Proteomic profiling reveals distinct inflammatory and neurogenic endotypes in rosacea [0.03%]
蛋白组学特征分析揭示了玫瑰痤疮不同的炎症和神经性亚型
Jundong Huang,Yifan Zhang,Caitan Yi et al.
Jundong Huang et al.
Background: Rosacea represents a chronic inflammatory dermatosis with potential systemic manifestations. While neuroimmune dysregulation and systemic inflammation are implicated in its pathogenesis, comprehensive proteomi...
Assessing the Protective Role of Sirolimus Against Non-Melanoma Skin Cancer: A Case Series [0.03%]
西罗莫司对抗非黑色素瘤皮肤癌保护作用的评估：一系列案例分析
Eva Shelton,Simran Kaur,Alexa Figueroa Baiges et al.
Eva Shelton et al.
The Effect of Isotretinoin Treatment for Acne Vulgaris on Height in Adolescents: A Retrospective Cohort Study Using the Rochester Epidemiology Project [0.03%]
异维A酸治疗痤疮对青少年身高影响的回顾队列研究（罗切斯特流行病学项目）
Kathryn K Xu,Nessa Aghazadeh,Peter Tebben et al.
Kathryn K Xu et al.
Background: Isotretinoin is the first line treatment for severe acne, but its effects on adolescent growth remain unclear. Objective: T...
Pitfalls of biopsy margin assessment: response to "Roland-McGowan JN, et al. Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision." [0.03%]
活检切缘评估的陷阱：关于“Roland-McGowan JN，等。开发一种治疗决策辅助工具，用于评估发育不良痣并考虑再次切除患者的治疗决策。”的回复
Margot S Peters,Shruti Agrawal,Jane M Grant-Kels
Margot S Peters
Abby Susan Van Voorhees
Abby Susan Van Voorhees
A Simulation-Based Strategy to Prioritize Melanoma Excision in Secondary Care [0.03%]
基于模拟的策略优先处理二级护理中的黑色素瘤切除手术
Calogero Pagliarello,Carlo Renè Girardelli
Calogero Pagliarello
Systemic risk profiles of topical ruxolitinib and oral Janus kinase inhibitors in patients with atopic dermatitis: A retrospective cohort study from the TriNetX network [0.03%]
一项关于特应性皮炎患者的局部鲁索利替尼和口服Janus激酶抑制剂的系统风险特征的回顾队列研究（来自TriNetX网络）
Katherine Benandi,Andrew Spires,Alyssa Hansen et al.
Katherine Benandi et al.
Background: Topical ruxolitinib is a Janus-activated kinase (JAK) inhibitor used to treat atopic dermatitis. The U.S. Food and Drug Administration issued a boxed warning for topical ruxolitinib, assuming it carries simila...
Growth of Dermatology House Calls in the Medicare Population: A National Medicare Analysis [0.03%]
医疗保险人群皮肤科家庭护理的增长：一项国家医疗保险分析
Timothy Klufas,Erik Choi,Albert E Zhou et al.
Timothy Klufas et al.